Dana-Farber Cancer Institute, 450 Brookline Avenue

450 Brookline Avenue
Boston, Massachusetts 02215

We've found

1 trials

at this facility

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Boston, MA

Use our guide to learn which trials are right for you!